• Latest

AustralaSian COVID-19 Trial opens in India

March 1, 2021
Conch Lifescience Strengthens Its Position as a Leading Nutraceutical Manufacturer in India with 150+ FSSAI-Approved Formulations and Upgraded Manufacturing Capacity

Conch Lifescience Strengthens Its Position as a Leading Nutraceutical Manufacturer in India with 150+ FSSAI-Approved Formulations and Upgraded Manufacturing Capacity

November 7, 2026
Moscow International Game Week Discusses Cooperation with India and Emerging Market Trends

Moscow International Game Week Discusses Cooperation with India and Emerging Market Trends

November 6, 2026
Major Projects and Export Orders Drives Continued Business Growth for KSB Limited in Q3 FY 2026

Major Projects and Export Orders Drives Continued Business Growth for KSB Limited in Q3 FY 2026

November 6, 2026
IRIS RegTech Reports Strong Q2 FY27 Performance; Revenue up 35% YoY, Robust SaaS Momentum Drives ARR Growth

IRIS RegTech Reports Strong Q2 FY27 Performance; Revenue up 35% YoY, Robust SaaS Momentum Drives ARR Growth

November 6, 2026
RMZ Strengthens Its Sustainability Leadership with Global and Regional Sector Leader Recognition in GRESB 2026

RMZ Strengthens Its Sustainability Leadership with Global and Regional Sector Leader Recognition in GRESB 2026

November 5, 2026
Sunny Diamonds Opens Signature Showroom in Chennai Ahead Of Diwali

Sunny Diamonds Opens Signature Showroom in Chennai Ahead Of Diwali

November 5, 2026
Dnyaan Prasad Global University (DPGU), Pune, Offers Students a Global Learning Experience in the UAE Through Joint Certification and Corporate Exposure

Dnyaan Prasad Global University (DPGU), Pune, Offers Students a Global Learning Experience in the UAE Through Joint Certification and Corporate Exposure

November 5, 2026
Royal Society of Chemistry signs MOU with India’s Science and Technology Clusters under Principal Scientific Advisor’s Office

Royal Society of Chemistry signs MOU with India’s Science and Technology Clusters under Principal Scientific Advisor’s Office

November 5, 2026
1Crowd Partially Exits Mojro, Retains 75% of Its Holding

1Crowd Partially Exits Mojro, Retains 75% of Its Holding

November 3, 2026
Moscow Ranks Among the World’s Top Three Video Game Development Hubs

Moscow Ranks Among the World’s Top Three Video Game Development Hubs

October 31, 2026
Dil Se Diwali, Dil Se Gifting: FNP Unveils Its Diwali 2026 Collection

Dil Se Diwali, Dil Se Gifting: FNP Unveils Its Diwali 2026 Collection

October 30, 2026
Inkle, the U.S. CPA Firm Built in Bengaluru, Acquires Finally’s Bookkeeping Division

Inkle, the U.S. CPA Firm Built in Bengaluru, Acquires Finally’s Bookkeeping Division

October 29, 2026
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Monday, November 9, 2026
  • Login
Mharo Rajasthan
  • Home
  • Rajasthan
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • Rajasthan
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
Mharo Rajasthan
No Result
View All Result

AustralaSian COVID-19 Trial opens in India

Mharo Rajasthan Team by Mharo Rajasthan Team
March 1, 2021
in Health & Fitness, National
Reading Time: 2 mins read
A A
0
Share on FacebookShare on Twitter

New Delhi: AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christian Medical College and Hospital Ludhiana in Punjab and Sterling Multispecialty Hospital in Pune, Maharashtra. Australasia is a region that comprises Australia, New Zealand, and some neighboring islands.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.George Institute for Global Health is an independent medical research institute headquartered in Australia with offices in China, India and the United Kingdom.

You May AlsoLike This

The Growing Role of Metabolic Surgery in Managing Obesity-Related Health Problems, Explained by Dr. Amit Sood

The Growing Role of Metabolic Surgery in Managing Obesity-Related Health Problems, Explained by Dr. Amit Sood

October 13, 2026
Lifevision Healthcare Offers Third-Party Pharma Manufacturing for Tablets, Capsules, and Syrups

Lifevision Healthcare Offers Third-Party Pharma Manufacturing for Tablets, Capsules, and Syrups

October 3, 2026

ASCOT aims to discover which existing treatments are most effective in patients hospitalised with COVID-19 and whether they will prevent patients deteriorating to the point of needing a ventilator in the Intensive Care Unit.

ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials in the country with a presence in 21 states.

ASCOT Principal Investigator, Associate Professor Steven Tong, a Royal Melbourne Hospital infectious diseases clinician and co-lead of clinical research at the Doherty Institute said that while ASCOT began as an Australian and New Zealand trial, expanding internationally to allow more widespread access to investigational treatments was crucial.

“A key principle of the trial is equity in terms of access to experimental treatments that could potentially have benefits for patients,” Associate Professor Tong said.

“The ASCOT Management Team and Leadership Group recognised early in the course of the trial that for it to have generalisability, external validity and be adequately powered, it would need to be expanded to international sites.”

India, like many other middle and low-income countries, is facing a severe epidemic of COVID-19. The number of patients with COVID-19 in India remains significantly higher than in Australia and New Zealand, and access to experimental treatments is limited.

Bala Venkatesh, Professorial Fellow at the George Institute for Global Health, said that while there are other ongoing clinical trials in India for COVID-19, the novel combinations of treatments included in ASCOT will provide greater opportunities to patients for accessing new treatments.

“We are confident that the study questions being asked are of priority to Indian patients and participating trial sites, and feasible to address in India,” said Professor Venkatesh.

One new treatment that’s recently been added to ASCOT is Nafamostat, which in laboratory experiments has shown to block SARS-COV-2 from entering human cells and be far more potent than Remdesivir.

“Nafamostat is mainly used in Korea and Japan as a treatment for acute pancreatitis and some blood clotting conditions. Of all drugs with potency data from laboratory studies using human cell lines, nafamostat appears to be the most potent against SARS-CoV-2 and maybe the only drug where blood concentrations almost always exceed levels required to stop the virus from replicating,” explained Associate Professor Tong.

“It is also likely that Nafamostat will reach high levels in the lungs where the SARS-CoV-2 virus causes so much of its problems. What’s more, it has a favourable safety profile.”

The ASCOT Steering Committee recently made the decision to cease enrolment into the convalescent plasma arm of the trial following a media release issued by the UK’s RECOVERY trial, which reported no benefit to patients compared with standard of care. (India Science Wire)

Tags: ASCOTAustralaSianChristian Medical College and HospitalClinical TrialCOVID-19Sterling Multispecialty Hospital
Share160Tweet100Share28SendSharePin36Send
Previous Post

Dr. Harsh Vardhan dedicates two new databases to the nation

Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Mharo Rajasthan Team

Mharo Rajasthan Team

Related Posts

The Growing Role of Metabolic Surgery in Managing Obesity-Related Health Problems, Explained by Dr. Amit Sood
Health & Fitness

The Growing Role of Metabolic Surgery in Managing Obesity-Related Health Problems, Explained by Dr. Amit Sood

October 13, 2026
Lifevision Healthcare Offers Third-Party Pharma Manufacturing for Tablets, Capsules, and Syrups
Health & Fitness

Lifevision Healthcare Offers Third-Party Pharma Manufacturing for Tablets, Capsules, and Syrups

October 3, 2026
Sugarfit RCT Shows Significant HbA1c and Weight Reduction in 90 Days, and GLP-1 Care Scales to 12,000 Users
Health & Fitness

Sugarfit RCT Shows Significant HbA1c and Weight Reduction in 90 Days, and GLP-1 Care Scales to 12,000 Users

August 26, 2026
CarePass Launches This Independence Day, Bringing Healthcare Savings Across India’s Top and Premium Hospitals
Health & Fitness

CarePass Launches This Independence Day, Bringing Healthcare Savings Across India’s Top and Premium Hospitals

August 17, 2026
Understanding the Benefits of Metabolic Surgery for Patients with Diabetes, High Blood Pressure and Thyroid Disorders
Health & Fitness

Understanding the Benefits of Metabolic Surgery for Patients with Diabetes, High Blood Pressure and Thyroid Disorders

June 30, 2026
VinayakM Introduces a New Paradigm in Women’s Mental Health and Happiness in South Delhi
Health & Fitness

VinayakM Introduces a New Paradigm in Women’s Mental Health and Happiness in South Delhi

June 5, 2026
Next Post

Synthesis of agonist molecule by CSIR-IICT for COVAXIN

Sublethal exposure study of lead (Pb) on black clams to provide early warning information on marine pollution

“Data and Artificial Intelligence are growing sectors among new job clusters”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Conch Lifescience Strengthens Its Position as a Leading Nutraceutical Manufacturer in India with 150+ FSSAI-Approved Formulations and Upgraded Manufacturing Capacity

Conch Lifescience Strengthens Its Position as a Leading Nutraceutical Manufacturer in India with 150+ FSSAI-Approved Formulations and Upgraded Manufacturing Capacity

November 7, 2026
Moscow International Game Week Discusses Cooperation with India and Emerging Market Trends

Moscow International Game Week Discusses Cooperation with India and Emerging Market Trends

November 6, 2026
Major Projects and Export Orders Drives Continued Business Growth for KSB Limited in Q3 FY 2026

Major Projects and Export Orders Drives Continued Business Growth for KSB Limited in Q3 FY 2026

November 6, 2026

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • India
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Rajasthan
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • World
Mharo Rajasthan

© 2022 Mharo Rajasthan

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Follow Us

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 Mharo Rajasthan

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In